Literature DB >> 34653635

Regulatory roles of phytochemicals on circular RNAs in cancer and other chronic diseases.

Shasha Zhang1, Fangyi Long2, Hong Lin1, Xi Wang1, Gang Jiang1, Ting Wang3.   

Abstract

As novel non-coding RNAs (ncRNAs), circular RNAs (circRNAs) play an essential role in the pathogenesis of many chronic diseases, and the regulation of these functional molecules has become a research hotspot gradually. Within the past decade, phytochemicals were reported to regulate the expression of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in various chronic diseases, and more recently, most studies focus on the regulatory roles of phytochemicals on circRNAs. Abnormal expression of circRNAs has been identified in chronic diseases like cancer, heart failure, depression and atherosclerosis, and numerous studies have revealed the modulation of circRNAs by phytochemicals including berberine, celastrol, cinnamaldehyde, curcumin, et al. The expression of circRNAs, such as circSATB2 and circFOXM1, were modulated by phytochemicals, and these regulations further affected cell proliferation, apoptosis, migration, invasion, autophagy, chemosensitivity, radiosensitivity and other biological processes. Mechanismly, the circRNAs mainly functioned as miRNA sponge, subsequently affecting miRNA-mediated regulation of target genes and related cell signaling pathways. In this review, we summarized the impact of phytochemicals on circRNAs expression and biological function, and discussed the mechanisms underlying phytochemicals regulating circRNAs in cancer and other chronic diseases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Berberine (PubChem CID: 2353); Bufalin (PubChem CID:9547215); Cancer; Celastrol (PubChem CID: 122724); Cinnamaldehyde (PubChem CID: 637511); Circular RNAs; Curcumin (PubChem CID: 969516); Emodin (PubChem CID: 3220); Gambogic acid (PubChem CID: 9852185); Genistein (PubChem CID:5280961); Lycorine (PubChem CID:72378); Matrine (PubChem CID:91466); Naringenin (PubChem CID: 932); Non-coding RNAs; Paclitaxel (PubChem CID: 36314); Panax notoginseng saponins (PubChem CID: 297); Phytochemicals; Puerarin (PubChem CID: 5281807); Quercetin (PubChem CID: 5280343); Tanshinone IIA (PubChem CID: 164676)

Mesh:

Substances:

Year:  2021        PMID: 34653635     DOI: 10.1016/j.phrs.2021.105936

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  3 in total

Review 1.  Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.

Authors:  Hong Lin; Yuxi Wang; Pinghan Wang; Fangyi Long; Ting Wang
Journal:  Mol Cancer       Date:  2022-07-18       Impact factor: 41.444

Review 2.  Accentuating CircRNA-miRNA-Transcription Factors Axis: A Conundrum in Cancer Research.

Authors:  Deepti Singh; Prashant Kesharwani; Nabil A Alhakamy; Hifzur R Siddique
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

3.  Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents.

Authors:  Jichao Chen; Yiping Duan; Xiaoxuan Yu; Jiarou Zhong; Jing Bai; Nian-Guang Li; Zheying Zhu; Jinyi Xu
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.